| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $241.6M | +158.5% |
| Cost of Revenue | $87.5M | +210.5% |
| Gross Profit | $154.1M | +136.1% |
| R&D Expense | $36.1M | +34.5% |
| SG&A Expense | $119.6M | +71.0% |
| Operating Income | -$28.7M | +8.6% |
| Interest Expense | $10.8M | +189.6% |
| Pre-tax Income | -$26.7M | +26.3% |
| Income Tax | -$1.7M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $394.8M | +96.2% |
| Accounts Receivable | $63.6M | +130.3% |
| Inventory | $44.2M | +114.7% |
| Current Assets | $510.7M | +102.4% |
| Total Assets | $706.0M | +154.8% |
| Current Liabilities | $54.9M | +132.2% |
| Total Liabilities | $568.8M | +533.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.0M | +71.6% |
| Capital Expenditures | $151.8M | +1175.3% |
| Investing Cash Flow | -$194.0M | -455.8% |
| Financing Cash Flow | $400.4M | +138.4% |
| Free Cash Flow | -$164.9M | -185.6% |
| -2675.8% |
| Net Income | -$25.0M | +30.9% |
| EPS (Basic) | -$0.77 | +37.4% |
| EPS (Diluted) | -$0.77 | +37.4% |
| Stockholders' Equity |
| $137.2M |
| -26.8% |